ISR — ISR Immune System Regulation Holding AB (publ) Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Nasdaq Stockholm Hands Over Investigation Of ISR Holding To Disciplinary Committee
Brief: ISR Immune System Regulation Holding Receives Notice Of Objection From Nasdaq
Brief: ISR FY 2022 Oper Loss Widens To SEK 205.1 Mln
Brief: ISR Signs Development Agreements With Catalent
Brief: ISR Immune System Regulation Holding Preclinical Study Shows Protection Against SARS-CoV-2
Brief: ISR Immune System Regulation Holding Signs Agreement With Gerresheimer
Brief: ISR: No Sign Of Toxicological Reactions For ISR Vaccine Candidate Against SARS-CoV-2
Brief: ISR Vaccine Enters Into MoU With Revitalife Holding Limited
Brief: ISR Immune System Regulation Holding Signs Agreement With Oncovir
Brief: ISR Unit Signs Vaccine Pipeline Agreement With Icosagen
Brief: ISR Enters Into LoI With Bumivac Ventures SDN BHD In Malaysia
Brief: ISR Signs Agreement To Start Vaccine Studies
Brief: ISR Signs Contract To Start Vaccine Study In Bangladesh
Brief: ISR H1 Pre-tax Loss Widens To SEK 24.7 Mln
Brief: ISR Enters Into MoU With UniMed UniHealth In Bangladesh
Brief: ISR Enters Into MoU Agreement To Start Vaccine Study In Bangladesh
Brief: ISR Signs Agreement Regarding Investment In Subsidiaries For Development Of Inhaled COVID-19 Vaccine
Brief: Iconovo Gets Order From ISR Regarding Nasal COVID-19 Vaccine
Brief: Isr Immune System Regulation Holding AB - Starts Cooperation With Inhalation Research Services